Status:
COMPLETED
Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma?
Lead Sponsor:
Institut Claudius Regaud
Conditions:
Sarcoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Pilot, prospective, monocentric study aimed at evaluating the rate of patients with circulating "cancer cell/macrophage" hybrid cells in the peripheral blood. The study will be conducted on a populat...
Eligibility Criteria
Inclusion
- Patient with one of the following subtypes of soft tissue or bone sarcomas: leiomyosarcoma, dedifferentiated liposarcoma, myxoid liposarcoma, synovialosarcoma, osteosarcoma, Ewing's sarcoma.
- Diagnosis of sarcoma histologically confirmed by the RRePS network (Réseau de Référence en Pathologie des Sarcomes et des Viscères)
- Age ≥ 18 years old.
- Localized or metastatic disease or recurrent disease.
- Patient who has not yet initiated specific treatment for sarcoma.
- Patient affiliated to a Social Health Insurance in France.
- Patient having signed informed consent prior to inclusion in the study and prior to any specific study procedures.
Exclusion
- Patient with any other histological subtype of sarcoma, including pleomorphic sarcoma.
- Associated pathology(s) that may prevent the proper conduct of the procedure under consideration.
- Pregnant or breastfeeding woman.
- Any psychological, family, geographical or sociological condition that prevents compliance with the medical follow-up and/or procedures of the study protocol.
- Patient who has forfeited his/her freedom by administrative or legal award or who is under legal protection (curatorship and guardianship, protection of justice).
Key Trial Info
Start Date :
October 22 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 2 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04512495
Start Date
October 22 2020
End Date
December 2 2021
Last Update
December 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Universitaire du Cancer de Toulouse - Oncopole
Toulouse, France, 31059